Motor Function Measure - 32 items (MFM-32)

Bérard C; Payan C; Hodgkinson I; Fermanian J; MFM Collaborative Study Group


Basic description

  • Published in 2005
  • Another version exist for pediatrics: MFM-20
  • In order to familiarize examiners with the use of the MFM and its rigorous scoring principles, a training session is required. For routine clinical use, this training may be administered ideally by taking part in a training session with video support

Bérard C; Payan C; Hodgkinson I; Fermanian J; MFM Collaborative Study Group

Motor Function Measure© is protected by international copyright with all rights reserved to the MFM steering committee. Don’t use without permission.
For all information and authorization to use the Motor Function Measure©, please contact contact@mfm-nmd.org
To monitor the severity and progression of motor function in most neuromuscular diseases
Therapeutic area
  • Nervous System Diseases
  • Musculoskeletal Diseases
  • Congenital, Hereditary, and Neonatal Diseases and Abnormalities
  • Rare disease (Orphanet definition)
Therapeutic indication
  • Muscular Dystrophy, Duchenne For more information on this rare disease, please consult the following link: Orphanet page
  • Muscular Dystrophy, Facioscapulohumeral
  • Muscular Dystrophies, Limb-Girdle
  • Myotonic Dystrophy
  • Muscular Atrophy, Spinal
  • Myopathies, Structural, Congenital
  • Muscular Dystrophies
  • Neuromuscular Diseases
Type of Clinical Outcome Assessment (COA)
  • clinro ClinRO
Original language(s)
  • French
  • English
11 translation(s)
Bibliographic reference(s) of the original questionnaire

Bérard C, Payan C, Hodgkinson I, Fermanian J; MFM Collaborative Study Group. A motor function measure for neuromuscular diseases. Construction and validation study. Neuromuscul Disord. 2005 Jul;15(7):463-70 (PubMed abstract)

Member Access

Subscribe to PROQOLID to access to full information

Access to advanced descriptions of Clinical Outcome Assessments (COAs)

A question? Contact us